Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC)

Margaret C Watson, Christine M Bond, Grampian Evidence Based Community Pharmacy Guidelines Group

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In the UK, there has been a rapid increase in the reclassification of prescription only medicines (POMs) to pharmacy only (P) and general sales list (GSL) status. This means that community pharmacy staff have a greater range of non-prescription medicines to recommend for the treatment of minor illness. Strategies are needed to promote good professional practice in the supply of non-prescription medicines. Guidelines have been shown to promote quality of care in other health care settings. In this article, we present evidence based guidelines for the treatment of vulvovaginal candidiasis using non-prescription anti-fungal medicines.

Original languageEnglish
Pages (from-to)129-134
Number of pages6
JournalPharmacy World & Science
Volume25
Issue number4
DOIs
Publication statusPublished - Aug 2003

Keywords

  • Antifungal Agents
  • Candidiasis, Vulvovaginal
  • Clinical Trials as Topic
  • Community Pharmacy Services
  • Evidence-Based Medicine
  • Female
  • Great Britain
  • Humans
  • Nonprescription Drugs
  • Quality Assurance, Health Care
  • Self Medication

Fingerprint Dive into the research topics of 'Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC)'. Together they form a unique fingerprint.

  • Cite this

    Watson, M. C., Bond, C. M., & Grampian Evidence Based Community Pharmacy Guidelines Group (2003). Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC). Pharmacy World & Science, 25(4), 129-134. https://doi.org/10.1023/A:1024819515862